Pfizer CEO: Metsera deal gives us ‘one of the most exciting, advanced portfolios’ in obesity drugsNovember 10, 2025
Share Facebook Twitter LinkedIn Pinterest Email Jim Cramer breaks down why he’s keeping an eye on shares of Tyson Foods.